Multi-epitopic oncomicrobial vaccine

Multi-epitopic oncomicrobial vaccine has been studied in 1 paper since 2026: none in people yet, 1 review; 1 in the past year. No study of it in people or animals has been published yet. The newest paper, May 28, 2026: “Anti-ETBF = "Anti-aging"? Breaking the Microbial Loop of Human Mortality through Anti-Aging Vaccines”.

Intervention

1 paper studies it1 findingUpdated

See all 1 papers on multi-epitopic oncomicrobial vaccine

What did studies of multi-epitopic oncomicrobial vaccine find?

1

Studies of multi-epitopic oncomicrobial vaccine measured one outcome, Fragipain-fragilysin cascade.

Fragipain-fragilysin cascade

downin reviews1

1 study
  1. Multi-epitopic oncomicrobial vaccine inhibits fragipain-fragilysin cascade.

    “designed to permanently neutralize the fragipain-fragilysin cascade”

    Reviewmulti-epitopic

    Anti-ETBF = "Anti-aging"? Breaking the Microbial Loop of Human Mortality through Anti-Aging Vaccines

    Zenodo (CERN European Organization for Nuclear Research)Preprint

Latest

Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 1Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 0Nov 2026: 01 paper in 12 months